This trial is testing whether Voraxaze, when given with the standard treatment for CNSL, is more effective than the standard treatment alone.
1 Primary ยท 0 Secondary ยท Reporting Duration: 1 year
Experimental Treatment
44 Total Participants ยท 8 Treatment Groups
Primary Treatment: Voraxaze ยท No Placebo Group ยท Phase < 1
Age 18+ ยท All Participants ยท 10 Total Inclusion Criteria
Mark โYesโ if the following statements are true for you: